openPR Logo
Press release

Trends in the Depression Drugs Market 2017-2027

04-13-2017 02:05 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Depression is a serious mood disorder which causes a persistent feeling of sadness and loss of interest thus affecting daily routine activities such as sleeping, walking, talking, thinking, eating etc. depression is different from temporary feeling of sadness. Signs and symptoms of depression includes persistent sadness, irritability, loss of interest in daily routine activities, feelings of worthlessness and pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight changes, restlessness, and suicide attempts however alcoholism and drug abuse may also be the signs of depression. Signs and symptoms of depression vary from person to person depending upon the risk factors and individual thinking and lifestyle. Also there are different forms of depression which has unique character tics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also categorised based on its severity as mild, moderate and severe. Psychotic depression, persistent depressive disorder and bipolar disorder are the severe form of depression and should be treated with anti-depressants and psychotherapies. Depression can occur at any age but often initiates in adulthood.

Depression drugs market comprises of the drugs which cures signs and symptoms caused by the depression, these drugs are known as anti-depressants. Anti-depressants includes tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants, and monoamine oxidase inhibitors. These drugs are also utilized in the treatment of a number of other mood disorders such as anxiety disorders, eating disorders, and obsessive compulsive disorder.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3290

Depression Drugs Market: Drivers and Restraints

Depression drugs market is growing, this is attributed to increasing prevalence of depression and other mood disorders with increasing availability of various anti-depressants in the market. Factors such as increasing reliance on medications for controlling the symptoms of depression is expected to contribute significantly to the depression drugs market revenue in the near future. In addition to this, growing healthcare expenditure, and rising insurance coverage also aids the growth of depression drugs market as increasing number of relatives of depressive cases are adopting early measures to halt the deterioration process. Also, availability of newer anti-depressants drives the depression drugs market, giving enormous opportunities to the companies within this market. However side effects associated with these drugs along with availability of other treatment methods such as psychotherapy is anticipated to hamper the revenue growth of depression drugs market over the forecast period.

Depression DrugsMarket: Overview

Depression drugs market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period attributed to increasing number of patients suffering from mild to moderate depression along with the availability of more drugs in the market. Also the depression drugs market is expanding globally due to increasing distribution partnerships among depression drug manufactures. The Depression Drugs market is expected to grow with a fastest CAGR over the forecast period due to increasing number of pipeline antidepressants. Increasing competition among major companies in the market to develop new formulation drugs which cures more than one symptoms also drives the depression drugs market towards the growth curve.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3290

Depression Drugs Market: Region-wise Outlook

Depending on geographic region, the depression drugs market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the largest regional market owing to high patient awareness levels regarding availability of various drugs for depression, rising healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing etc. these factors contribute for significant revenue generation from the region.

Asia Pacific excluding Japan is expected to grow at the fastest CAGR because of increasing prevalence of depression and mood disorders in the region along with more focus of the companies to target the markets such as India and China leads to increase in the revenue growth of depression drugs market throughout the forecast period.

Depression Drugs Market: Key Players

Some of the players in depression drugs marketinclude AstraZeneca, GlaxoSmithKline, Merck & Co., SK Biopharmaceuticals, Novartis, Forest Laboratories, Naurex etc. whereas some and regionalplayers also have a significant presence in depression drugs market.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Trends in the Depression Drugs Market 2017-2027 here

News-ID: 500810 • Views: 179

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Depression

Global Depression Treatment Therapy Market Research and Forecast, 2018-2023
Increasing Cases of Depression Will Accentuate the Growth of Global Depression Treatment Therapy Market According to OMR analysis, the global depression treatment therapy market is estimated to grow with a significant CAGR during the forecast period. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders is driving the market. However, North America and Europe region are currently leading the market. They make up for
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Global Depression Drugs Market Analysis & Forecast with Upcoming Trends 2022
Global Info Reports has published its new and latest market report based on thorough research on the Depression Drugs Market. This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%
Animal Depression Medication Market – Global Industry Analysis 2024
Animal Depression Medication Market Overview Emotions may be described as subjective, conscious experiences characterized by psychophysiological expressions, mental states, and biological reactions. Several tests such as cognitive bias test and leaned helplessness models have been developed to understand feelings of optimism and pessimism in animals. Cognitive biases have been shown in wide range of species, including rats, dogs, cats, sheep, and chicks. Get Free PDF Research Brochure for more Professional and Technical